MediLynx Cardiac Monitoring

MediLynx Cardiac Monitoring is a U.S. cardiac diagnostics and remote monitoring company focused on ambulatory ECG and arrhythmia detection services. The company commercializes PocketECG-based monitoring solutions, including mobile cardiac telemetry, extended Holter, event monitoring, and related reporting and support services for cardiology practices and hospitals. MediLynx has positioned itself as a technology-enabled arrhythmia diagnostics provider, highlighting cloud-based ECG data transmission, near-real-time analysis, and artificial intelligence-enabled signal processing. The business has also participated in clinical research collaborations, including an NHLBI/NIH-funded study evaluating mobile cardiac monitoring in post-CABG patients. MediLynx was previously majority owned by Medicalgorithmics and was sold in 2022 to a buyer associated with React Health, after which support and product supply arrangements with Medicalgorithmics continued.